PT680346E - Metodo para aumentar a concentracao de oxido nitrico no sangue - Google Patents

Metodo para aumentar a concentracao de oxido nitrico no sangue

Info

Publication number
PT680346E
PT680346E PT93904180T PT93904180T PT680346E PT 680346 E PT680346 E PT 680346E PT 93904180 T PT93904180 T PT 93904180T PT 93904180 T PT93904180 T PT 93904180T PT 680346 E PT680346 E PT 680346E
Authority
PT
Portugal
Prior art keywords
blood
nitric oxide
concentration
increasing
increasing nitric
Prior art date
Application number
PT93904180T
Other languages
English (en)
Inventor
Anthony E Bolton
Original Assignee
Vasogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasogen Inc filed Critical Vasogen Inc
Publication of PT680346E publication Critical patent/PT680346E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Agression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0216—Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
PT93904180T 1992-02-07 1993-02-08 Metodo para aumentar a concentracao de oxido nitrico no sangue PT680346E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83279892A 1992-02-07 1992-02-07
US94132692A 1992-09-04 1992-09-04

Publications (1)

Publication Number Publication Date
PT680346E true PT680346E (pt) 2002-10-31

Family

ID=27125561

Family Applications (2)

Application Number Title Priority Date Filing Date
PT02014086T PT1243278E (pt) 1992-02-07 1993-02-08 Utilização de sangue tendo uma concentração aumentada de óxido nítrico para o fabrico de um medicamento
PT93904180T PT680346E (pt) 1992-02-07 1993-02-08 Metodo para aumentar a concentracao de oxido nitrico no sangue

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT02014086T PT1243278E (pt) 1992-02-07 1993-02-08 Utilização de sangue tendo uma concentração aumentada de óxido nítrico para o fabrico de um medicamento

Country Status (13)

Country Link
US (1) US5834030A (pt)
EP (2) EP0680346B1 (pt)
JP (1) JP3989949B2 (pt)
AT (2) ATE350046T1 (pt)
AU (1) AU681999B2 (pt)
CA (1) CA2129630C (pt)
DE (2) DE69334101T2 (pt)
DK (2) DK0680346T3 (pt)
ES (2) ES2280454T3 (pt)
HK (1) HK1053068B (pt)
NZ (1) NZ249176A (pt)
PT (2) PT1243278E (pt)
WO (1) WO1993015779A1 (pt)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
US6204058B1 (en) 1992-02-07 2001-03-20 Vasogen Ireland Limited Treatment of autoimmune diseases
US6696092B2 (en) 1992-02-07 2004-02-24 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
JPH10506636A (ja) * 1995-05-05 1998-06-30 バソゲン・インコーポレーテッド 内皮ライニング効果及び血管痙攣性疾患の治療
AU760465B2 (en) * 1995-05-05 2003-05-15 Vasogen Ireland Limited Endothelial lining effects and treatment of vasospastic disorders
US6866755B2 (en) * 2001-08-01 2005-03-15 Battelle Memorial Institute Photolytic artificial lung
CA2206180A1 (en) * 1997-05-27 1998-11-27 Vasogen Inc. Treatment of chronic post-traumatic pain syndromes
US6087087A (en) * 1997-07-03 2000-07-11 Takashi Yonetani Treatment of hemoglobin with nitric oxide
IL135014A0 (en) * 1997-09-12 2001-05-20 Vasogen Ireland Ltd A pharmaceutical composition for treating stress comprising pretreated blood
JPH11217330A (ja) 1998-01-30 1999-08-10 Sumitomo Pharmaceut Co Ltd 神経栄養因子分泌促進剤
US6264646B1 (en) 1998-11-13 2001-07-24 Vasogen Ireland Limited Method for preventing and reversing atherosclerosis in mammals
US7045124B1 (en) * 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
EP1146885B1 (en) * 1999-01-12 2003-05-28 Centre De Recherche Du Centre Hospitalier De L'Universite De Montreal Pre-conditioning against cell death
AU3877800A (en) * 1999-03-30 2000-10-16 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
JP4258908B2 (ja) * 1999-09-14 2009-04-30 株式会社ジェイ・エム・エス 人工肺装置
ES2214314T3 (es) * 1999-09-16 2004-09-16 Vasogen Ireland Limited Aparato para acondicionar sangre de mamifero.
US7516742B2 (en) 1999-11-24 2009-04-14 Cardinal Health 207, Inc. Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
CA2309424A1 (en) * 2000-05-25 2001-11-25 Vasogen Ireland Limited Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders
AU8484901A (en) * 2000-08-11 2002-02-25 David R Whitlock Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
NL1015999C2 (nl) * 2000-08-23 2002-02-26 A J Van Liebergen Holding B V Inrichting voor het verwarmen van bloed of andere fysiologische vloeistoffen.
CA2327630A1 (en) * 2000-12-05 2002-06-05 Vasogen Ireland Limited Transforming growth factor regulation
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
EP1357936B1 (en) * 2001-01-16 2008-10-01 The Regents of The University of Michigan Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces
US7335383B2 (en) * 2001-01-16 2008-02-26 The Regents Of The University Of Michigan Generation of nitric oxide in vivo from nitrite, nitrate or nitrosothiols endogenous in blood
US7128904B2 (en) * 2001-01-16 2006-10-31 The Regents Of The University Of Michigan Material containing metal ion ligand complex producing nitric oxide in contact with blood
US7122208B2 (en) 2001-04-06 2006-10-17 Vasogen Ireland Limited Compositions containing apoptotic entities
AU2002322832A1 (en) * 2001-08-01 2003-02-17 Eric C. Burckle Photolytic cell for providing physiological gas exchange
US6472390B1 (en) * 2001-11-13 2002-10-29 Duke University Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure
CN1308438C (zh) * 2002-01-11 2007-04-04 大卫·R·怀特洛克 含有氨氧化细菌的化合物以及使用的方法
CA2377442A1 (en) * 2002-03-20 2003-09-20 Thomas Ichim Increasing tumor oxygen content by administration of stressed cells
AU2003218583A1 (en) * 2002-04-10 2003-10-27 Vasogen Ireland Ltd Electrocardiographic aspects of chf treatment
US7531133B2 (en) 2002-09-10 2009-05-12 Pulmonox Technologies Corporation Use of nitric oxide gas in an extracorporeal circuitry to treat blood plasma
US20100316727A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of inflammatory disorders with ozone
US20050051497A1 (en) * 2003-07-31 2005-03-10 Latino Joseph S. Viral inactivation using ozone
US20050189302A1 (en) * 2003-07-31 2005-09-01 Latino Joseph S. Viral inactivation using ozone
US7736494B2 (en) * 2003-07-31 2010-06-15 Acquisci, Inc. Ozone delivery system including a variable pitch gas-fluid contact device
US20100316730A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of cardiovascular diseases with ozone
US20100318014A1 (en) * 2003-07-31 2010-12-16 Latino Joseph S Treatment of acute ischemic brain stroke with ozone
JP2007508247A (ja) * 2003-09-26 2007-04-05 ホイットロック，デービッド，アール． アンモニア酸化細菌の使用方法
CN100475275C (zh) * 2004-01-05 2009-04-08 董永华 肿瘤血管栓塞剂及其储存和释放装置
MXPA06013111A (es) 2004-05-11 2007-05-23 Sensormedics Corp Dosificacion intermitente de gas de oxido nitrico.
US8518457B2 (en) 2004-05-11 2013-08-27 Pulmonox Technologies Corporation Use of inhaled gaseous nitric oxide as a mucolytic agent or expectorant
EP1773360A4 (en) * 2004-07-20 2009-09-02 Vasogen Ireland Ltd TREATMENT OF ACUTE INFLAMMATORY EVENTS
CN100420490C (zh) * 2005-04-13 2008-09-24 刘余厚 全自动紫外线照射充氧自血回输处理方法及设备
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
CA2632224A1 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same
US8079998B2 (en) 2006-10-20 2011-12-20 Pulmonox Technologies Corporation Methods and devices for the delivery of therapeutic gases including nitric oxide
US20080181832A1 (en) * 2007-01-30 2008-07-31 Lih-Ren Shiue Pocket-size ozone generator
ES2900298T3 (es) * 2013-02-28 2022-03-16 Hemanext Inc Dispositivo de agotamiento de gas para productos sanguíneos
ITMI20131667A1 (it) * 2013-10-09 2015-04-10 Ind Paolo Gobbi Frattini Metodo per pre-trattare le cellule ematiche prima della separazione.
KR20210100224A (ko) 2014-04-15 2021-08-13 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis
MA39958B1 (fr) * 2014-05-09 2018-10-31 Thankstem S R L Procédé d'expansion de cellules souches adultes à partir de sang total
SE541036C2 (en) 2014-09-15 2019-03-12 Sangair Ab Apparatus and system for ozonating blood, and method for ozonating blood prior to storage
EP4295872A1 (en) * 2022-06-22 2023-12-27 Purotech S.r.l. Blood treatment apparatus

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US695647A (en) * 1901-10-30 1902-03-18 James Harold Warner Combination-tile for floors.
DE1068428C2 (de) * 1957-05-21 1960-04-21 Hermann Dr Med Jentjens Verfahren und Einrichtung zur Herstellung von oxygeniertrm Blut
US3325641A (en) * 1964-02-17 1967-06-13 George W Jones Apparatus for treating a thin film of liquid by exposure to radiant energy
US3715430A (en) * 1969-08-04 1973-02-06 E Ryan Purified oxygen gas containing ozone and higher oxygen polymers
DE2926523A1 (de) * 1979-06-30 1981-01-22 Margit Stadtlaender Geraet zur therapeutischen behandlung von blut und anderen koerpereigenen wie auch koerperfremden fluessigkeiten, substanzen und gasen zum zweck der therapeutischen wie auch diagnostischen anwendung in der human- wie auch veterinaermedinzin usw.
JPS58198466A (ja) * 1982-05-12 1983-11-18 Teijin Ltd ５−チアプロスタグランジン類およびその製造法
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE8704467U1 (de) 1987-01-15 1988-05-26 Quarzlampenfabrik Dr.-Ing. Felix W. Müller GmbH & Co KG, 45239 Essen Gerät zur Herstellung von oxygeniertem Blut
JPH01207070A (ja) * 1987-10-22 1989-08-21 Jr Robert E Duthie 滅菌方法および装置
ATE120375T1 (de) * 1988-04-29 1995-04-15 Medizone Int Inc Vorrichtung für die gesteuerte generierung und verabreichung von ozon.
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human

Also Published As

Publication number Publication date
EP1243278A3 (en) 2003-02-26
ATE219953T1 (de) 2002-07-15
EP0680346A1 (en) 1995-11-08
ATE350046T1 (de) 2007-01-15
EP0680346B1 (en) 2002-07-03
DK1243278T3 (da) 2007-05-07
DK0680346T3 (da) 2002-10-28
US5834030A (en) 1998-11-10
HK1053068B (zh) 2007-03-30
WO1993015779A1 (en) 1993-08-19
EP1243278B1 (en) 2007-01-03
PT1243278E (pt) 2007-04-30
DE69332087D1 (de) 2002-08-08
EP1243278A2 (en) 2002-09-25
AU3506393A (en) 1993-09-03
AU681999B2 (en) 1997-09-18
DE69334101T2 (de) 2007-10-04
ES2179828T3 (es) 2003-02-01
JP3989949B2 (ja) 2007-10-10
DE69332087T2 (de) 2002-10-24
JPH07503722A (ja) 1995-04-20
DE69334101D1 (de) 2007-02-15
CA2129630C (en) 2003-09-23
CA2129630A1 (en) 1993-08-08
ES2280454T3 (es) 2007-09-16
NZ249176A (en) 1996-11-26
HK1053068A1 (en) 2003-10-10

Similar Documents

Publication Publication Date Title
PT680346E (pt) Metodo para aumentar a concentracao de oxido nitrico no sangue
DE10299002I1 (de) Verwendung von No zur Behandlung oder Praevention der Bronchokonstriktion
DE69001503D1 (de) D-cycloserin und d-alanin enthaltende mischung zur verbesserung des gedaechtnisses und des lernvermoegens oder zur behandlung von kognitiven und psychotischen erkrankungen.
DE69102695D1 (de) Behandlung von verunreinigten abwässern und bodenwässern.
ATE67092T1 (de) Verwendung von chlordioxidgas als chemisches sterilisierungsmittel.
DE58904364D1 (de) Anordnung zur bestrahlung von laufenden fluessigkeiten und/oder gasen mit ultraviolett.
DE69422669T2 (de) Vorrichtung und Methode zur optischen Bestimmung von Konzentrationen
NO20005800D0 (no) Fremgangsmåte og apparat for inaktivering av forurensninger i biologisk fluid
ES2178681T3 (es) Procedimiento y aparato para el tratamiento de fluidos.
SE8802781D0 (sv) Forfarande for avfuktning av gaser
DE69432279T2 (de) Methode und Katalysator zur Behandlung von Dioxinen enthaltenden Rauchgasen
ATE111785T1 (de) Anordnung zur gasbehandlung von verunreinigtem erdreich.
DE69429299T2 (de) Verwendung von Tachykinin-Antagonisten zur Behandlung von Erbrechen
BR8904423A (pt) Catalisador e processo para o tratamento de gas contendo compostos de enxofre
DE69308879D1 (de) Methode zur behandlung von abfallverbrennungsrückständen und deren verwendung als adsorptionsmittel
DE68900917D1 (de) Behandlungsverfahren fuer zyanid und/oder sonstige oxidierbare stoffe enthaltenden abwaessern.
ATE37484T1 (de) Zusammensetzung zur vorbeugung und behandlung von mycoplasma-pneumonie.
DE58900998D1 (de) Verfahren zur entgiftung eines durch chromat belasteten bodens.
DE69309464T2 (de) Verfahren zur Reinigung von Ethalfluralin
DE3370766D1 (en) Process for the reduction of the content of so2 and/or nox in flue gas
DE69021584D1 (de) Behandlung von abgas.
JPS51119672A (en) Denitrating method
BR9002788A (pt) Processo para tratamento de residuos contendo pelo menos um cianeto e/ou um cianeto
ATE89192T1 (de) Anordnung zur bestrahlung von laufenden fluessigkeiten und/oder gasen mit ultraviolett.
BR8006819A (pt) Processo e aparelho para o tratamento fisico-quimico de efluentes industriais e esgotos